Alpha-ketoanalogues are nitrogen-free analogues of essential amino acids. They are used in the management of chronic kidney disease (CKD) to reduce the accumulation of nitrogenous waste products (urea) by transamination into their corresponding essential amino acids, utilizing the body's own nitrogen from urea. This process helps lower blood urea nitrogen (BUN) levels, reduces uremic symptoms, and may slow the progression of renal damage by decreasing the dietary protein load on the kidneys. In India, they are a cornerstone of conservative management for CKD stages 3-5, often used as part of a low-protein diet regimen.
Adult: Typically 4-8 tablets (approx. 600-1200 mg of active ketoanalogues) three times daily with meals. Exact dose is based on body weight and degree of renal impairment, usually 0.1-0.2 g/kg/day. Must be individualized.
Note: Take tablets with meals (during the meal is ideal) to facilitate transamination with dietary nitrogen. Do not crush or chew unless specified by the brand. Swallow whole with a full glass of water. Must be combined with a low-protein, high-calorie diet as prescribed.
Alpha-ketoanalogues are structurally similar to essential amino acids but lack the alpha-amino group. When administered orally, they are absorbed and undergo transamination in the body, primarily in the liver and muscle. The amino group for this conversion is derived from non-essential amino acids and, crucially, from urea via the urea cycle intermediates. This process effectively recycles nitrogenous waste, reducing the net nitrogen load that the kidneys must excrete. By supplementing essential amino acid requirements without adding exogenous nitrogen, they help maintain positive nitrogen balance and reduce the generation of uremic toxins like urea and creatinine.
Pregnancy: Category C: Animal reproduction studies have not been conducted. Use only if clearly needed and potential benefit justifies the potential risk to the fetus. Requires strict supervision by an obstetrician and nephrologist.
Driving: No known effects on driving ability. However, severe hypercalcemia can cause confusion or drowsiness.
| Vitamin D and analogues (Calcitriol, Cholecalciferol) | Increased risk of hypercalcemia and hypercalciuria | Major |
| Thiazide diuretics (Hydrochlorothiazide) | Increased risk of hypercalcemia due to reduced calcium excretion | Major |
| Calcium supplements | Additive risk of hypercalcemia | Major |
| Oral Tetracyclines, Fluoroquinolones (Ciprofloxacin, Levofloxacin) | Calcium salts can chelate these antibiotics, significantly reducing their absorption and efficacy | Major |
| Levothyroxine | Calcium can impair its absorption. Administer at least 4 hours apart. | Moderate |
| Bisphosphonates (Alendronate) | Calcium interferes with absorption. Administer at different times of the day. | Moderate |
| Digoxin | Hypercalcemia can potentiate digoxin toxicity, leading to arrhythmias. | Major |
Same composition (Alpha Ketoanalogue (NA)), different brands: